JPS5229320B1 - - Google Patents

Info

Publication number
JPS5229320B1
JPS5229320B1 JP46087235A JP8723571A JPS5229320B1 JP S5229320 B1 JPS5229320 B1 JP S5229320B1 JP 46087235 A JP46087235 A JP 46087235A JP 8723571 A JP8723571 A JP 8723571A JP S5229320 B1 JPS5229320 B1 JP S5229320B1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP46087235A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS5229320B1 publication Critical patent/JPS5229320B1/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Analytical Chemistry (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
JP46087235A 1970-11-03 1971-11-04 Pending JPS5229320B1 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT31308/70A IT1043823B (it) 1970-11-03 1970-11-03 Procedimento per l estrazione di acidi nucleici da organi animali

Publications (1)

Publication Number Publication Date
JPS5229320B1 true JPS5229320B1 (enExample) 1977-08-01

Family

ID=11233430

Family Applications (1)

Application Number Title Priority Date Filing Date
JP46087235A Pending JPS5229320B1 (enExample) 1970-11-03 1971-11-04

Country Status (7)

Country Link
US (1) US3770720A (enExample)
JP (1) JPS5229320B1 (enExample)
DE (2) DE2154278A1 (enExample)
FR (2) FR2131248A5 (enExample)
GB (2) GB1366647A (enExample)
IT (1) IT1043823B (enExample)
SE (2) SE385376B (enExample)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5967214A (ja) * 1982-10-12 1984-04-16 Kazuo Suga 化粧品組成物
EP0107161B1 (de) * 1982-10-26 1989-08-09 CTA Finanz AG Mittel und Verfahren zur Optimierung der Gewebemasse von Organen innerhalb der genetischen Schwankungsbreite bei Menschen und Tieren
IT1170214B (it) * 1983-09-12 1987-06-03 Crinos Industria Farmaco Composizione farmaceutica per la cura delle arteriopatie periferiche
IT1170215B (it) * 1983-09-12 1987-06-03 Crinos Industria Farmaco Composizione farmaceutica per il trattamento di stati di insufficienza renale acuta
IT1206341B (it) * 1984-02-16 1989-04-14 Crinos Industria Farmaco Composizione farmaceutica per il trattamento dell'ischemia acuta del miocardio.
IT1187833B (it) * 1985-12-12 1987-12-23 Farmigea Spa Procedimento per l ottenimento di polidesossiribonucleotidi non informazionali sostanzialmente puri e dotati di attivita biologiche e prodotto relativo
IT1190313B (it) * 1986-04-17 1988-02-16 Crinos Industria Farmaco Procedimento per l'ottenimento di polidesossiribonucleotidi chimicamente definiti e riproducibili e prodotto farmacologicamente attivo risultante
IT1212143B (it) 1987-06-26 1989-11-08 Crinos Industria Farmaco Composizione ad attivita'tricogena.
IT1222701B (it) * 1987-09-23 1990-09-12 Crinos Industria Farmaco Composizione ad uso topico avente attivita' tricogena,antiforfora ed antiseborroica
IT1223322B (it) * 1987-10-23 1990-09-19 Crinos Industria Farmaco Metodo per prevenire la formazione di coaguli sanguigni nel circuito extracorporeo di apparecchi di dialisi a composizione utile per esso
IT1231509B (it) * 1989-09-07 1991-12-07 Crinos Industria Farmaco Composizione farmceutica ad uso topico per la terapia della fragilita' capillare.
US6699985B2 (en) * 1991-08-21 2004-03-02 Arsinur Burcoglu Method of treating HIV infection and related secondary infections thereof
US5977083A (en) * 1991-08-21 1999-11-02 Burcoglu; Arsinur Method for using polynucleotides, oligonucleotides and derivatives thereof to treat various disease states
IT1252174B (it) * 1991-12-09 1995-06-05 Crinos Industria Farmaco Oligodesossimibonucleotidi ad attivita' antiischemica e procedimenti per il loro ottenimento
US7683035B1 (en) * 1999-02-23 2010-03-23 Qiagen, Gmbh Method of stabilizing and/or isolating nucleic acids
ES2251134T3 (es) 1999-06-08 2006-04-16 Gentium S.P.A. Uso de complejos entre liposomas cationicos y polidesoxirribonucleotidos como medicamentos.
US6323743B1 (en) * 1999-08-24 2001-11-27 Tresness Irrevocable Patent Trust Electronic filter assembly
EP1147777A1 (en) 2000-04-18 2001-10-24 Crinos Industria Farmacobiologica S.p.A. Combination of defibrotide and G-CSF and its use to activate haematopoietic progenitors
US8771663B2 (en) * 2000-04-18 2014-07-08 Gentium Spa Formulation having mobilising activity
ITMI20031714A1 (it) * 2003-09-05 2005-03-06 Gentium Spa Formazioni ad azione antitumorale.
KR20070121001A (ko) * 2005-03-03 2007-12-26 젠티엄 에스피에이 신혈관 형성-의존성 종양 치료용 약학적 제제
EP1872787A1 (en) * 2006-06-27 2008-01-02 Gentium S.p.A. Use of defibrotide for the inhibition of heparanase
EP1982722A1 (en) * 2007-04-16 2008-10-22 Gentium S.p.A. Use of oligotide for the treatment of renal diseases
EP2103689A1 (en) 2008-03-19 2009-09-23 Gentium S.p.A. Synthetic phosphodiester oligonucleotides and therapeutical uses thereof
CN107007617A (zh) 2010-11-12 2017-08-04 真蒂奥姆责任有限公司 去纤维蛋白多核苷酸用于预防和/或治疗移植物抗宿主病(gvhd)
WO2013190582A1 (en) 2012-06-22 2013-12-27 Gentium S.P.A. Euglobulin-based method for determining the biological activity of defibrotide
EP3026122A1 (en) 2014-11-27 2016-06-01 Gentium S.p.A. Cellular-based method for determining the potency of defibrotide
CA3071544A1 (en) 2017-08-03 2019-02-07 Jazz Pharmaceuticals Ireland Limited Formulations comprising a nucleic acid in a high concentration
AU2019252790A1 (en) 2018-04-12 2020-10-15 Jazz Pharmaceuticals, Inc. Defibrotide for the prevention and treatment of cytokine release syndrome and neurotoxicity associated with immunodepletion
US20220023533A1 (en) 2018-12-07 2022-01-27 Jazz Phrmaceticals Ireland Limited Subcutaneous delivery of high concentration formulations
WO2021174039A1 (en) 2020-02-28 2021-09-02 Jazz Pharmaceuticals Ireland Limited Delivery of low viscosity formulations
US20230086833A1 (en) 2020-04-17 2023-03-23 Jazz Pharmaceuticals Ireland Limited Defibrotide treatment for the prevention of organ rejection and injury
TW202308659A (zh) 2021-05-06 2023-03-01 愛爾蘭商爵士製藥愛爾蘭有限責任公司 用於急性呼吸窘迫症候群之治療及預防的去纖維蛋白多核苷酸

Also Published As

Publication number Publication date
GB1366647A (en) 1974-09-11
US3770720A (en) 1973-11-06
FR2131248A5 (enExample) 1972-11-10
SE385376B (sv) 1976-06-28
SE385902B (sv) 1976-07-26
IT1043823B (it) 1980-02-29
FR2131249A5 (enExample) 1972-11-10
DE2154277C2 (enExample) 1988-04-07
DE2154277A1 (de) 1972-05-25
DE2154278A1 (de) 1972-05-25
GB1367656A (en) 1974-09-18

Similar Documents

Publication Publication Date Title
FR2085797B1 (enExample)
FR2086419B1 (enExample)
JPS5229320B1 (enExample)
FR2097188A1 (enExample)
FR2086238B3 (enExample)
FR2081547B1 (enExample)
FR2086099B1 (enExample)
FR2081076B1 (enExample)
FR2129614A5 (enExample)
FR2086212B1 (enExample)
FR2081616B1 (enExample)
FR2272131B1 (enExample)
FR2086156A1 (enExample)
FR2112218A1 (enExample)
JPS4819950B1 (enExample)
FR2086259A1 (enExample)
FR2081444B1 (enExample)
FR2131253A5 (enExample)
FR2086237B3 (enExample)
FR2112143B3 (enExample)
FR2110968A5 (enExample)
FR2111017A5 (enExample)
FR2081296A1 (enExample)
FR2081272B1 (enExample)
FR2081219A7 (enExample)